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Apoptosis: Telling cells their time is up
Shigekazu Nagata
Ligand engagement by the receptor Fas leads to
apoptosis. A clue to how this happens comes from the
discovery that ligand binding leads to recruitment to
Fas of a protease, homologous to interleukin-1b
converting enzyme, likely to initiate a proteolytic
cascade that drives apoptosis.
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Apoptosis, or programmed cell death, occurs during
embryogenesis, metamorphosis and the turnover of senes-
cent cells [1]. In some cases, apoptosis occurs when cells
lack a ‘survival’ factor, well-known examples of which are
the neurotrophins of the nervous system. In other cases, an
external stimulus, such as g irradiation or an anti-cancer
drug, causes cells to undergo apoptosis. An apoptosis-
inducing signal can also be delivered via a cell-surface
receptor, the best-known example being Fas in the
immune system. Fas, also called APO-1 or CD95, is a type I
membrane protein, which belongs to the tumor necrosis
factor (TNF) receptor family, whereas the Fas ligand
(FasL) is a member of the TNF family. Binding of FasL, a
homotrimer, induces the trimerization of Fas, leading to
cell death with all the morphological hallmarks of apoptosis
— cytoplasmic condensation, loss of plasma membrane
microvilli and nuclear condensation and segmentation [2]. 
Like Fas, the TNF type I receptor (TNF-RI) also trans-
duces an apoptotic signal. Fas and TNF-RI have a homolo-
gous region of about 80 amino acids in their cytoplasmic
domains, which is essential for transduction of the death
signal and hence known as a death domain [3,4]. This death
domain provides the link between cell-surface receptors
such as TNF-RI and Fas and the intracellular apoptosis
machinery. Recent results are beginning to unravel the
chain of events that follows engagement of the Fas receptor
and tells a cell that its time is up.
Unlike classical apoptosis, which is defined as a type of cell
death that requires gene expression [1], apoptosis induced
by Fas or TNF-RI stimulation occurs in the presence of
inhibitors of RNA or protein synthesis. Even enucleated
cells undergo apoptosis upon Fas activation, suggesting that
all the components necessary for the apoptotic signal trans-
duction are present in the growing cells, and that Fas activa-
tion just triggers this machinery. To dissect the signal
transducing machinery proximal to the Fas receptor, two
approaches have been taken. Several groups used the yeast
two-hybrid system to clone directly molecules that can bind
to the Fas cytoplasmic region, while one group used more
biochemical techniques to identify such molecules. Use of
the yeast two-hybrid system quickly identified several mol-
ecules that can bind to Fas [5,6]. One of these is a molecule
known as the  FADD (Fas-associating protein with a death
domain) or MORT1, a 208-residue protein with a death
domain at its carboxyl terminus. FADD/MORT1 binds to
Fas via interactions between the death domains, while its
amino-terminal region — the DED (death-effector domain)
or MORT1 domain — is responsible for the downstream
signal transduction. Subsequently, FADD/MORT1 was
shown to be recruited to Fas when the latter is activated by
ligand binding [7].
Meanwhile, several groups have shown an involvement of
interleukin-1b (IL-1b) converting enzyme (ICE), or an
ICE-like protease, in Fas-mediated apoptosis [8]. This
strand of the story has its origins in genetic studies with the
nematode Caenorhabditis elegans, which identified a number
of genes that regulate apoptosis [9]. Among these genes,
CED-3 was shown to be essential for the cell deaths that are
a normal part of Caenorhabditis elegans development, and
cloning of CED-3 showed that its product is a homologue of
mammalian ICE [10]. ICE was originally identified as the
enzyme that converts the IL-1b precursor to the mature
form, an inflammatory cytokine. ICE is a cysteine protease
consisting of two large (p17) and two small (p10) subunits,
which are generated by proteolytic cleavage of its precursor.
ICE has turned out to be the prototype of a protease family
that so far is known to have seven members, identified
either by cross-hybridization with ICE cDNA or by search-
ing the human genome database for ICE homologues; the
family has been divided into three subgroups based on
sequence relationships [11]. All of these seem to be cysteine
proteases, having the characteristic conserved sequences for
substrate binding and catalysis. Although in most cases the
substrate specificities of the ICE homologs are not known,
some clearly recognize a specific peptide sequence. Thus,
ICE recognizes the sequence YVAD, cleaving after the
aspartate (D), whereas CPP32 recognizes DEVD and
cleaves poly(ADP-ribose) polymerase, and Mch2 recognizes
VEVD and cleaves lamin [12–14]. Despite this apparent
specialization, ICE mutant mice lack an obvious phenotype,
which suggests that there is at least an element of functional
redundancy among members of the ICE family [15].
A good way of investigating the function of an enzyme is
to use specific inhibitors, and there are several ways of
inhibiting ICE family proteases. Knowledge of the spe-
cific sequences that they recognize has been used to
design specific competitive inhibitors of ICE itself and
CPP32. Thus, Ac-YVAD-aldehyde (cho) specifically
inhibits ICE, whereas Ac-DEVD-cho inhibits CPP32. In
addition, several virus proteins are known to inhibit ICE:
these are the cowpox virus protein crmA, a ‘cytokine
response modifier’, and the baculovirus protein p35. Using
these inhibitors, it was shown that both ICE and CPP32
proteases are involved in Fas-mediated apoptosis [8,16].
By monitoring the protease activity of ICE and CPP32
using specific fluorescent substrates, it was demonstrated
that ICE is transiently activated, and CPP32 more gradu-
ally activated, during Fas-induced apoptosis [16]. The
activation of CPP32 is dependent on ICE activation, indi-
cating that ICE and CPP32 are sequentially activated; this
sequential protease activation has also been demonstrated
in a cell-free system. Lysates from the Fas-activated, but
not from non-activated cells, induce apoptotic morpholog-
ical changes in intact nuclei [17]. When the lysates from
the growing, non-apoptotic cells were supplemented with
recombinant ICE or CPP32, they gained the ability to
induce apoptosis. This ICE-induced apoptosis could be
inhibited not only by an ICE inhibitor, but also by the
CPP32 inhibitor [16], confirming that their sequential acti-
vation really does reflect a pathway leading to apoptosis.
Ligand binding to Fas thus induces a protease cascade
inside the Fas-expressing cell. But how does the intracellu-
lar domain of Fas, once activated, trigger this cascade? In an
attempt to find the signaling molecule immediately down-
stream of FADD/MORT1, Wallach and colleagues [18]
again used the yeast two-hybrid system, this time with the
amino-terminal region of FADD/MORT1 as a bait. At the
same time, a collaborative group led by Dixit and Peter [19]
continued their biochemical characterization of the mole-
cules that are recruited to oligomerized Fas. In these differ-
ent ways, both groups have now identified the same
molecule, which is called FLICE (FADD-like ICE) or
MACH (MORT1-associated CED-3 homologue).
FLICE/MACH is a 55 kDa protein, with two DED/
MORT1 domains in the amino-terminal region required
for binding to FADD/MORT1. A truncated form of the
FLICE/MACH protein, containing only its amino-termi-
nal DED domain, is also found associated with FADD/
MORT1 [19]. This fragment may be generated by prote-
olytic processing of FLICE/MACH: activation of FLICE/
MACH may release the carboxy-terminal, ICE-like
domain, leaving the amino-terminal part attached to
FADD/MORT1. The other possibility is the fragment is a
product of alternative RNA splicing. Several mRNA
species that code for just the amino-terminal part of
FLICE/ MACH have been identified [18]. Overexpres-
sion of this amino-terminal fragment blocks Fas-induced
apoptosis, suggesting that the sensitivity of the cells to the
Fas-induced apoptosis is determined at least in part by
alternative splicing of FLICE/MACH mRNA. 
The carboxy-terminal region of FLICE/MACH is related
to the ICE family members, more specifically to the
members of the CPP32 subfamily, and recombinant
MACH preferentially cleaves CPP32 substrates over the
ICE substrates [18]. The following two models seem plau-
sible ways of integrating these results into the sequential
activation model of ICE proteases. In the first model, the
oligomerization of FLICE/MACH through interaction
with FADD/MORT1 leads to the autocatalytic activation
of FLICE/MACH, which then triggers the protease
cascade by cleavage of the ICE precursor (Fig. 1). In the
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Figure 1
Fas-induced ICE protease cascade. Binding of Fas ligand to Fas
receptor causes trimerization of Fas. The trimerized Fas cytoplasmic
region recruits FLICE/MACH via the docking protein FADD/MORT1,
which may cause the activation of FLICE by autolysis. The activated
FLICE then triggers the ICE protease cascade. Each ICE member would
activate the downstream protease by proteolysis, and may also cleave
the specific death substrates. (PARP is poly(ADP–ribose) polymerase.)
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second model, the oligomerization itself does not activate
FLICE/MACH, but ICE, or an ICE-like protease, acti-
vates the oligomerized FLICE/MACH, which then acti-
vates other members of the ICE family, such as CPP32,
Mch2 and Mch3. In any case, the identification of an ICE-
like protease that can be directly recruited to the Fas
receptor suggests that the apoptotic process induced by
the Fas activation is much simpler than expected.
The other remarkable feature of FLICE/MACH is the
homology of its amino-terminal DED/MORT1 domain
with the C. elegans CED-4 protein. CED-4 is a 548-residue
protein required for apoptosis in C. elegans [20]. No mam-
malian homologue of CED-4 has been identified yet. As
shown in Figure 2, however, the DED/MORT domains of
FLICE/MACH and FADD show significant homology to
the carboxy-terminal region of CED-4. This suggests either
that a putative mammalian CED-4 homologue is also
recruited to the Fas receptor through FADD/MORT1, or
that FLICE/MACH binds to the putative CED-4 homo-
logue through its DED/MORT1 domain. The CED-4
product is necessary for CED-9 to block apoptosis [21].
Bcl-2, a mammalian homolog of CED-9, inhibits the Fas-
induced apoptosis in vitro as well as in vivo [22,23]. These
observations may facilitate the analysis of Bcl-2 and CED-
4, the functions of which are currently unknown.
In conclusion, the signal transduction mechanism
leading to apoptosis was until recently obscure. The
identification of a death-inducing ligand and receptor,
and of intracellular signaling molecules downstream of
the receptor, has shown that the decision to undergo
apoptosis is an irreversible step involving a cascade of
proteases. This apoptotic pathway seems to be much
simpler than those involved in growth or differentiation,
and could be a model for mechanisms by which other
agents, such as anti-cancer drugs, oncogenes and irradia-
tion, induce apoptosis. Various important human dis-
eases, such as cancer and some autoimmune diseases, are
often caused by inappropriately regulated apoptosis; the
identification of the apoptotic signaling molecules and
their modulators should certainly help further our under-
standing of such diseases.
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Figure 2
Presence of DED domain in the C. elegans
CED-4 protein. The amino-acid sequences
from FLICE/MACH, FADD/MORT1 and C.
elegans CED4 are aligned to maximize their
similarity. Amino acids that are identical or
chemically similar among all three
sequences are indicated by red letters, with
and without yellow highlighting, respectively.
FLICE(3-57)	 FSRNLYDI GEQLDSEDLASLKFLSLDYIPQRKQEPIKDALMLFQRLQ––EKRMLEES
FADD(4-61)	 FLVLLHSV SSSLSSSELTELKFLCLGRVGKRKLERVQSGLDLFSML––LEQNDLEPG
CED4(422-480)	DRLKRLSK GALLSGKRMPVLTF–KIDHIIHMFLKHVVDAQTIANGISILEQRLLEIG
